Brief Vaping Exposure Leaves Lasting Damage in the Lung’s Deepest Tissue, Study Finds

A few days of exposure to e-cigarette vapor may be enough to injure the most delicate tissue in the human lung and to weaken its defenses against respiratory viruses, according to a new study led by researchers at National Jewish Health and published in JCI Insight. The findings, reported in preclinical models using human lung cells and tissue, suggest that even short-term vaping can initiate injury in the distal lung, the deep region where oxygen crosses into the bloodstream, and that some of the damage persists well after the exposure itself has ended.

The research team focused on the distal lung because it is both the site of gas exchange and the most vulnerable part of the respiratory system. Working with human lung epithelial and endothelial cells, as well as precision-cut human lung tissue, the investigators exposed these samples to e-cigarette vapor alone and, in separate experiments, exposed them to vapor followed by infection with a respiratory virus. Within just 24 hours of vapor exposure, the researchers observed damage to the protective barrier of the distal lung, the layer of cells that keeps the airspaces sealed and selectively controls what passes between the air and the blood.

The early cellular response was broad. Vapor exposure triggered cellular stress, impaired autophagy, the internal recycling process cells use to clear damaged components, slowed cell growth and repair, and increased cell death. Each of these processes is central to maintaining the integrity of the alveolar-capillary barrier. When barrier function is compromised, fluid and immune cells can leak into the airspaces, and the lung becomes less able to perform its essential task of transferring oxygen while keeping airborne threats out of the circulation.

Perhaps the most striking result was the persistence of injury. Signs of lung stress remained detectable 10 days after a five-day exposure period had ended. The team documented lasting changes in barrier function, tissue remodeling, and Th1 immunity, a branch of the adaptive immune system that is critical for mounting effective responses against viral infections. Tissue remodeling in the distal lung is a particular concern because, if sustained, it can interfere with the fine architecture of the alveoli and contribute to chronic scarring and reduced lung capacity.

The antiviral consequences were equally significant. In the preclinical models, prior vaping exposure increased the viral burden of SARS-CoV-2 following infection and suppressed several antiviral genes. These genes encode proteins that detect viral genetic material, interfere with viral replication, and recruit immune cells to infected tissue. Their suppression means that when a virus arrives, the lung’s early-warning and containment systems are blunted, potentially allowing the pathogen to replicate to higher levels before an effective immune response can be organized.

Senior author Irina Petrache, MD, a pulmonologist and chief of the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health, summarized the implications of the work. Our findings suggest that even short-term vaping exposure can initiate injury in the deepest and most delicate regions of the lung, she said. Importantly, some effects persisted after exposure ended and altered the immune response to a subsequent viral infection. That combination, acute injury followed by lingering immune alteration, is what distinguishes the current findings from earlier work that focused mainly on the immediate effects of vapor exposure.

The study helps explain, at a mechanistic level, why epidemiological and clinical observations have repeatedly linked vaping to lung injury and to greater susceptibility to respiratory infections. Rather than a single toxic event, the research points to a sequence: vapor exposure damages the barrier and stresses the cells, the cells’ repair machinery is slowed, and the immune programming of the tissue shifts in ways that reduce antiviral readiness. Repeated cycles of exposure, the researchers noted, could potentially contribute to chronic lung disease by sustaining cellular injury and disrupting normal repair processes over time.

Technically, the use of precision-cut human lung tissue is an important strength of the study. Unlike isolated cell lines, precision-cut slices preserve the three-dimensional structure of the distal lung, including the relationships between epithelial cells, endothelial cells, and the extracellular matrix that supports them. This means the observed barrier disruption and remodeling reflect interactions among multiple cell types rather than the response of a single cell population. The parallel use of epithelial and endothelial cultures allowed the team to separate contributions from the airside and bloodside linings of the barrier, both of which showed evidence of stress and dysfunction after vapor exposure.

The authors emphasize that the findings will need to be confirmed in future studies in people. Preclinical models, even those built from human cells and tissue, cannot fully capture the complexity of vaping in real-world users, who differ in the devices they use, the e-liquids they inhale, the frequency and depth of their puffing, and their baseline health. Human exposure histories are also far more variable than a controlled five-day exposure regimen. Nonetheless, the demonstration that a brief exposure window can produce measurable and persistent changes in human distal lung tissue provides a biological rationale for concern that complements the population-level associations reported in prior research.

For public health, the message is that risk is not confined to long-term, heavy vaping. If days of exposure can alter barrier integrity, autophagy, repair capacity, and Th1 antiviral immunity in human distal lung tissue, then occasional or new users may not be as protected as commonly assumed, particularly during respiratory virus season. The study also offers researchers concrete mechanistic targets, including barrier repair pathways, autophagy regulation, and antiviral gene expression, that could guide future investigations into which components of e-cigarette vapor drive injury and whether the effects are reversible once exposure stops. As e-cigarette use continues to evolve, work of this kind provides the cellular-level evidence needed to assess its consequences for lung health with greater precision.

Subject of Research: Effects of brief e-cigarette vapor exposure on human distal lung tissue and antiviral immune defenses

Article Title: Even brief e-cigarette use can cause lasting lung damage and weaken defenses against respiratory viruses, study finds

Article References: Even brief e-cigarette use can cause lasting lung damage and weaken defenses against respiratory viruses, study finds. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: e-cigarettes, vaping, lung injury, distal lung, epithelial barrier, autophagy, Th1 immunity, SARS-CoV-2, antiviral genes, JCI Insight, National Jewish Health, respiratory infection